GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Amalgamated Bank

Amalgamated Bank boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.2% in the 4th quarter, HoldingsChannel reports. The fund owned 91,688 shares of the company’s stock after acquiring an additional 4,513 shares during the period. Amalgamated Bank’s holdings in GE HealthCare Technologies were worth $7,168,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. LGT Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the last quarter. Capital Performance Advisors LLP acquired a new stake in GE HealthCare Technologies during the third quarter worth approximately $26,000. Ashton Thomas Securities LLC purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Darwin Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $31,000. Finally, Continuum Advisory LLC grew its position in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 0.2 %

NASDAQ:GEHC opened at $90.67 on Thursday. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock’s 50 day simple moving average is $85.76 and its 200-day simple moving average is $86.05. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The firm has a market cap of $41.46 billion, a P/E ratio of 20.94, a PEG ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on GEHC shares. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company raised their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.